INHIBACE PLUS

This brand name is authorized in Austria, Canada, Spain, Poland, Turkey, South Africa

Active ingredients

The drug INHIBACE PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Cilazapril
UNII 19KW7PI29F - CILAZAPRIL

Cilazapril is a specific, long-acting angiotensin-converting enzyme (ACE) inhibitor which suppresses the renin-angiotensin-aldosterone system and thereby the conversion of the inactive angiotensin I to angiotensin II, which is a potent vasoconstrictor.

Read about Cilazapril
2 Hydrochlorothiazide
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.

Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C09BA08 Cilazapril and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02181479
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60649
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100096008
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699511099034
Country: ZA Health Products Regulatory Authority Identifier(s): 29/7.1.3/0022

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.